Skip to main content
. 2022 Sep 24;14(19):3978. doi: 10.3390/nu14193978

Figure 5.

Figure 5

Mon attenuates TRAP activity and actin ring formation in BMMs. (A) Phalloidin staining to detect F-actin ring formation of osteoclast in response to Mon treatment. BMMs were incubated with M-CSF (30 ng/mL), RANKL (20 ng/mL) for 48 h and then treated with different concentrations of Mon (0.1, 1, and 10 µM) in present of 30 ng/mL M-CSF, 200 ng/mL LPS for 6 days and then stained with phalloidin (n = 3). (B) TRAP activity of osteoclasts in response to Mon treatment (n = 6). The data are expressed as means ± SD. ** p < 0.01 compared with ctrl group.